Videos

What if you could help someone with dementia by giving them a big, old hug? Might sound crazy, but neuroscientist Philippos Koulousakis (UHasselt) explains why he looks at oxytocin, aka 'the hugging hormone', to boost the brains of patients with Alzheimer's disease.

Cancer patients often become heart patients. This is because chemotherapy affects not only cancer cells but also healthy cells, such as the heart muscle cells. In order to prevent heart damage after chemotherapy, we first need to know what factors increase the risk of heart damage. And that is what Sibren Haesen (Uhasselt) has made his mission. With his Ph.D., he wants to help ensure that today's cancer patients do not become tomorrow's heart patients.

An unborn child is exposed to air pollution even before he or she breathes for the first time. This is shown by the research of Eva Bongaerts (UHasselt). She found soot particles in the placenta of women who were only 12 weeks into their pregnancy. Watch the video.

Did you know that cancer cells are not so different from our healthy cells? This makes it difficult for T-cells, important immune cells in our body, to recognise and fight cancer cells. Cancer researcher Heleen Hanssens (VUB-FWO) wants to give T-cells a helping hand by equipping them with more sensitive receptors, or antennae, that are pre-programmed to unmask cancer cells. In the lab, she is looking for the perfect form for these CAR antennae, so that they become more stable and better at detecting cancer cells. 

Getting out of bed in the morning is quite a feat, and not just on Monday mornings. It requires a series of complex motor actions, which we perform without thinking, on automatic pilot. In patients with Parkinson's disease, these automatic actions are disturbed. Something goes wrong in the brain so that they suddenly have to think about every action. Mahyar Firouzi (VUB) is investigating whether brain stimulation can help to improve automatic action in Parkinson's patients.

Millions of people worldwide suffer from 'invisible' diseases such as chronic widespread pain and chronic fatigue syndrome, which makes patients feel ill for days or even weeks after a small effort, such as washing their hair. Jolien Hendrix (VUB - KU Leuven) tries to understand these diseases by looking at epigenetics. Epi what?! Well, you can see this as DNA paperclips as Jolien explains vividly in this video!

Someone who suffers a stroke often has to learn to walk again. Unfortunately, such rehabilitation - walking for hours on a treadmill - is often very boring and therefore difficult to maintain. "Let's make this more challenging", says Emma De Keersmaecker (VUB - FWO). She has patients complete their rehabilitation in a virtual environment using VR glasses, for example on Mars among aliens. "Walking on a treadmill will never have to be boring again!"

Imagine not being able to feel a hug anymore. This is what happens to some patients with Charcot-Marie-Tooth disease (CMT1A). They get weaker muscles, their muscles die and sometimes they even lose the sense of touch. In order to research the disease more quickly and efficiently, Karen Libberecht (UHasselt - VIB - FWO) studies her patients ... in a petri dish. She explains how that works exactly in this video.

Family parties are a nightmare for those who wear hearing aids. With all those people talking at the same time, they find it difficult to hold a conversation. Engineer Simon Geirnaert is working on a solution. With his brain-controlled hearing aids, he also wants to help people with a hearing aid to communicate with each other.

Do you remember baby Pia? She suffered from the rare muscle disease AMS and the medicine to save her cost a whopping €1.9 million. If you were the Minister of Health, would you pay for Pia's medicine? Even if that meant there was no budget left for another medicine that might save 100 people?

During a stroke, every second counts to save as many brain cells as possible. Intervention is only possible within a narrow time window of a few hours because late treatment can lead to serious complications. Is there nothing more we can do for these 'late' patients? There is, says neurologist trainee Lauranne Scheldeman!

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.